FDA issued a draft “Guidance for Industry and Food and Drug Administration Staff – Electronic Source Data in Clinical Investigations” Nov 30, 2012. The full document is at the link provided. It discusses the value of electronic source data for clinical investigations as well as types of controls to ensure integrity and trace origin.